Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

VEDA LAB

VEDALAB focuses on the development, production and marketing of in vitro immunodiagnostic reagents and instruments. I... read more Featured Products: More products

Download Mobile App





Vedalab Presents Wide Range of Quantitative Rapid Tests

By LabMedica International staff writers
Posted on 13 Nov 2023

Vedalab (Cerisé, France) is presenting its wide range of lateral flow qualitative rapid tests and rapid tests for home use alongside its new generation rapid test reader at MEDICA 2023. More...

Vedalab offers several rapid tests for drugs of abuse detection (one drug/test) for home use including cannabinoid, cocaine, opiates, amphetamines and methamphetamines. These tests are to be used with urine samples. Vedalab also offers an immunochromatographic rapid test for the qualitative detection of respiratory syncytial virus (RSV) and influenza A and B viruses in nasal or nasopharyngeal swab samples. This is in addition to its immunochromatographic rapid test for the quantitative detection of anti-spike (S1) IgM and IgG antibodies to SARS-CoV-2 virus in human whole blood, plasma, or serum samples. When used in combination with the VEDALAB Easy reader+ instrument, it can detect and quantify IgM and IgG antibodies to the spike SARS-CoV-2 protein produced after virus infection in human serum, plasma, or finger prick whole blood samples.

At MEDICA 2023, Vedalab is demonstrating the Easy reader+ POC reader that allows quantitative measurements from fingerprick whole blood samples using rapid lateral flow tests. The instrument includes the most advanced and up-to-date technologies (touch screen, enhanced memory, and internet upgrading). The quantitative lateral flow immunochromatography analyzer is intended to provide a quantitative immunochromatography assay result for a wide range of otherwise purely qualitative rapid test devices to increase the accuracy and efficiency of the home, point of care, and laboratory testing of the relevant marker analytes.

Related Links:
Vedalab 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Automated Immunoassay Analyzer
SuperFlex™
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Acute lymphoblastic leukemia in children and young people requires careful relapse risk assessment as treatment expands beyond standard chemotherapy. (Image Credit: Shutterstock)

New Risk-Stratification Tool Predicts Relapse After Blinatumomab in Childhood ALL

Acute lymphoblastic leukemia in children and young people requires careful assessment of relapse risk, particularly as treatment approaches move beyond standard chemotherapy. Traditional relapse predictors... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Decentralized Laboratory Network Improves Detection of Viral Hemorrhagic Fevers in Guinea

Viral hemorrhagic fevers remain a major diagnostic challenge in West Africa because their early symptoms can resemble those of other febrile illnesses. The 2014–2016 Ebola epidemic underscored the need... Read more

Pathology

view channel
Image Credit: Adobe Stock

AI Pathology Approach Closely Aligns With Breast Cancer Genomic Risk Classification

In early-stage breast cancer, precision oncology relies on biological information to guide personalized treatment decisions. Because access to tissue-based genomic testing may be limited, there is growing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.